))
Leqembi: Five insights on the first fully approved Alzheimer's drug
Manage episode 371292259 series 2793637
Contenu fourni par David E. Williams. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par David E. Williams ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Leqembi was just approved to treat early stage Alzheimer's. In this solo episode, host David Williams shares five thoughts.
- Leqembi is just different enough from Aduhelm to survive scrutiny
- Patient registry requirement is a good idea
- The delivery system isn't ready
- Health equity will suffer
- Public health and prevention would be money better spent
Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.
193 episodes
Partager
